Our R&D vision is to combine world-class science and innovation to discover, develop, and deliver new medicines that make a difference and improve patients' lives.
AstraZeneca is one of the world’s leading investors in biopharmaceutical research and development.
We are committed to delivering more new, medically important and commercially successful medicines and vaccines to the market every year.
In this section:
- Our pipeline: We are sharply focused on making breakthroughs in therapeutic areas of the future
- Discovery & development: We are transforming cutting edge science into meaningful medicines
- External collaborations: We are continuously seeking opportunities with like-minded partners that share our commitment to pursuing novel medical solutions
- Research responsibility: We are committed to innovative scientific studies of the highest quality, conducted to the highest ethical standards
- Leading biologics and vaccines capabilities: 25% of our portfolio is now in biologics
- Clinical trials: We conduct clinical trials to help determine the safety and efficacy of a new medicine
- Postmarketing study commitments: We track our US postmarketing commitment studies' progress
- Seeking new medicines: Every new medicine is the result of an intensive and focused research process
- North American R&D sites: Our global R&D organization operates 11 R&D sites around the world, including three in North America
- Excellence in chemistry: To reward individuals who contribute to the art of chemistry, we annually present the Excellence in Chemistry Award
